A Long-term Study for Participants Previously Treated With Ciltacabtagene Autoleucel

Summary

The purpose of this study is to collect long-term follow-up data on delayed adverse events after administration of ciltacabtagene autoleucel (cilta-cel), and to characterize and understand the long-term safety profile of cilta-cel.

Timeline

Start

2022-03-09

Primary completion

2037-07-29

Completion

2041-06-28

Drugs

Indications